NEW YORK (GenomeWeb News) — Microarrayer developer Aushon BioSystems has raised $7.8 million in a Series A financing round, the company said today.
 
Financing company North Bridge Venture Partners led the round, which ended on Oct. 12, Aushon said.
 
The early stage company, based in Burlington, Mass., makes microarrayers for protein, antibody, and cell research. Its clients include the National Institutes of Health, M.D. Anderson Cancer Center, and George Mason University.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.